<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Fisch MJ</submitter><funding>NCI NIH HHS</funding><pagination>1980-8</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3383175</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>30(16)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>Pain is prevalent among patients with cancer, yet pain management patterns in outpatient oncology are poorly understood.&lt;h4>Patients and methods&lt;/h4>A total of 3,123 ambulatory patients with invasive cancer of the breast, prostate, colon/rectum, or lung were enrolled onto this prospective study regardless of phase of care or stage of disease. At initial assessment and 4 to 5 weeks later, patients completed a 25-item measure of pain, functional interference, and other symptoms. Providers recorded analgesic prescribing. The pain management index was calculated to assess treatment adequacy.&lt;h4>Results&lt;/h4>Of the 3,023 patients we identified to be at risk for pain, 2,026 (67%) reported having pain or requiring analgesics at initial assessment; of these 2,026 patients, 670 (33%)</pubmed_abstract><journal>Journal of clinical oncology : official journal of the American Society of Clinical Oncology</journal><pubmed_title>Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer.</pubmed_title><pmcid>PMC3383175</pmcid><funding_grant_id>P30 CA016672</funding_grant_id><funding_grant_id>CA17145</funding_grant_id><funding_grant_id>U10 CA037403</funding_grant_id><funding_grant_id>U10 CA023318</funding_grant_id><funding_grant_id>U10 CA017145</funding_grant_id><funding_grant_id>R01 CA026582</funding_grant_id><funding_grant_id>CA37604</funding_grant_id><funding_grant_id>CA23318</funding_grant_id><funding_grant_id>CA026582</funding_grant_id><pubmed_authors>Wagner LI</pubmed_authors><pubmed_authors>Mendoza TR</pubmed_authors><pubmed_authors>Chang VT</pubmed_authors><pubmed_authors>Manola JB</pubmed_authors><pubmed_authors>McCaskill-Stevens W</pubmed_authors><pubmed_authors>Fisch MJ</pubmed_authors><pubmed_authors>Minasian LM</pubmed_authors><pubmed_authors>Cella D</pubmed_authors><pubmed_authors>Cleeland CS</pubmed_authors><pubmed_authors>Weiss M</pubmed_authors><pubmed_authors>Lee JW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer.</name><description>&lt;h4>Purpose&lt;/h4>Pain is prevalent among patients with cancer, yet pain management patterns in outpatient oncology are poorly understood.&lt;h4>Patients and methods&lt;/h4>A total of 3,123 ambulatory patients with invasive cancer of the breast, prostate, colon/rectum, or lung were enrolled onto this prospective study regardless of phase of care or stage of disease. At initial assessment and 4 to 5 weeks later, patients completed a 25-item measure of pain, functional interference, and other symptoms. Providers recorded analgesic prescribing. The pain management index was calculated to assess treatment adequacy.&lt;h4>Results&lt;/h4>Of the 3,023 patients we identified to be at risk for pain, 2,026 (67%) reported having pain or requiring analgesics at initial assessment; of these 2,026 patients, 670 (33%)</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Jun</publication><modification>2025-04-19T16:40:22.346Z</modification><creation>2019-03-27T00:54:54Z</creation></dates><accession>S-EPMC3383175</accession><cross_references><pubmed>22508819</pubmed><doi>10.1200/jco.2011.39.2381</doi><doi>10.1200/JCO.2011.39.2381</doi></cross_references></HashMap>